Bank of New York Mellon’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.1M | Buy |
|
|||||
|
2025
Q1 | $23.5M | Sell |
|
|||||
|
2024
Q4 | $30.2M | Sell |
|
|||||
|
2024
Q3 | $32.3M | Sell |
|
|||||
|
2024
Q2 | $40.2M | Sell |
|
|||||
|
2024
Q1 | $41.6M | Sell |
|
|||||
|
2023
Q4 | $44.2M | Sell |
|
|||||
|
2023
Q3 | $47.2M | Sell |
|
|||||
|
2023
Q2 | $45.5M | Sell |
|
|||||
|
2023
Q1 | $45.2M | Sell |
|
|||||
|
2022
Q4 | $44.1M | Sell |
|
|||||
|
2022
Q3 | $45.5M | Buy |
|
|||||
|
2022
Q2 | $38.9M | Sell |
|
|||||
|
2022
Q1 | $38.7M | Buy |
|
|||||
|
2021
Q4 | $31.1M | Buy |
|
|||||
|
2021
Q3 | $40.9M | Buy |
|
|||||
|
2021
Q2 | $37.1M | Buy |
|
|||||
|
2021
Q1 | $54.5M | Sell |
|
|||||
|
2020
Q4 | $59M | Sell |
|
|||||
|
2020
Q3 | $43.6M | Sell |
|
|||||
|
2020
Q2 | $48.7M | Sell |
|
|||||
|
2020
Q1 | $58.9M | Buy |
|
|||||
|
2019
Q4 | $65.6M | Sell |
|
|||||
|
2019
Q3 | $74.5M | Sell |
|
|||||
|
2019
Q2 | $76.9M | Sell |
|
|||||
|
2019
Q1 | $66.1M | Sell |
|
|||||
|
2018
Q4 | $82.3M | Sell |
|
|||||
|
2018
Q3 | $97.9M | Buy |
|
|||||
|
2018
Q2 | $70.5M | Buy |
|
|||||
|
2018
Q1 | $48.5M | Sell |
|
|||||
|
2017
Q4 | $38.6M | Sell |
|
|||||
|
2017
Q3 | $30.6M | Sell |
|
|||||
|
2017
Q2 | $28.5M | Sell |
|
|||||
|
2017
Q1 | $30.7M | Buy |
|
|||||
|
2016
Q4 | $29M | Buy |
|
|||||
|
2016
Q3 | $24.3M | Buy |
|
|||||
|
2016
Q2 | $18.5M | Sell |
|
|||||
|
2016
Q1 | $23.1M | Buy |
|
|||||
|
2015
Q4 | $20.9M | Sell |
|
|||||
|
2015
Q3 | $21M | Buy |
|
|||||
|
2015
Q2 | $21.9M | Buy |
|
|||||
|
2015
Q1 | $23.6M | Buy |
|
|||||
|
2014
Q4 | $19.4M | Buy |
|
|||||
|
2014
Q3 | $18M | Sell |
|
|||||
|
2014
Q2 | $18.4M | Sell |
|
|||||
|
2014
Q1 | $17.3M | Sell |
|
|||||
|
2013
Q4 | $33.1M | Buy |
|
|||||
|
2013
Q3 | $31.1M | Sell |
|
|||||
|
2013
Q2 | $32.7M | Buy |
|